U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07752277) titled 'Quantitative Pharmacology-Based Dose Adjustment Protocol in Postoperative Thyroid Cancer Patients' on Aug. 04.
Brief Summary: Through pharmacometric approaches-including modeling, mathematics, and statistics-this work aims to refine the levothyroxine sodium tablet (brand name: Euthyrox) dosing strategy in post-thyroidectomy cancer patients, enabling individualized precision dosing to minimize side effects and maximize therapeutic outcomes.
Study Start Date: Dec. 06, 2022
Study Type: OBSERVATIONAL
Condition:
Thyroid and Other Endocrine Gland Carcinoma in Situ
Recruitment Status: COMPLETED
Sponsor: Zhejiang Provincial People's Ho...